Dari, Rhoujhan .

HRN: 21-20-11  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2022
CEFUROXIME 750MG (VIAL)
06/09/2022
06/15/2022
IV
317mg
Q8
PCAP C
Waiting Final Action 
06/14/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/14/2022
06/20/2022
IVT
150mg
OD
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: